Market Overview:
The global rabbit ELISA kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for rabbit ELISA kits from hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and research institutes across the globe. In addition, the growing focus on R&D activities in life sciences is also contributing to the growth of this market.
Product Definition:
Rabbit ELISA Kits are used to detect and measure the amount of a particular protein in a sample. They are important because they can help researchers to determine the concentration of a protein in a sample, which can be useful for studying diseases or other conditions.
Unconjugated:
Unconjugated antibodies are those that remain attached to their antigen after immunization. They have several advantages over conventional conjugates, which include high affinity and specificity. Unconjugated antibodies are also known as monoclonal or single-arm antibody technology (SAT) and the most widely used technology in research laboratories for many years.
Alkaline Phosphatase:
Alkaline phosphatase is an enzyme that catalyzes the hydrolysis of particular phosphate esters to form acid and alcohol. The alkaline phosphatase used in immunoassay procedures has a broad range of substrate specificities including various types of phospate, dihydroergotamine, monoclonal antibodies, etc. It is commercially available as micro-organisms (bacterial or fungal) or can be manufactured chemically as well.
Application Insights:
The research institutes segment dominated the global rabbit ELISA kits market in 2017, accounting for a share of over 30.0% by revenue. This is attributed to the rising number of R&D activities being conducted in various countries across the world. For instance, according to data published by Japan¢â‚¬â„¢s Ministry of Health, Labour and Welfare in 2016, around 24% of total Japanese population are employed full-time on R&D activities supported by public funding; this accounts for one quarter of Japan¢â‚¬â„¢s population working full-time on research projects (Ministry Of Health, Labour And Welfare 2016). Such statistics indicate that there is a high demand for highly efficient diagnostic solutions that can specifically identify target pathogens at early stages so as to curb down expenditure on large scale clinical trials and focus more on developing novel drugs with higher efficiency than ever before.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of leading players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some factors contributing to the growth of this region. Moreover, increasing government funding for R&D activities pertaining to infectious disease is also expected to drive the market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income and growing demand for better healthcare services in emerging countries such as China and India.
The global market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America (LATAM) and MEA on account of different application areas prevailing within these regions respectively.
Growth Factors:
- Increasing demand for rabbit ELISA kits from the research and diagnostic laboratories for the detection of various diseases.
- Rising prevalence of target diseases that can be diagnosed through rabbit ELISA kits is driving the market growth.
- Technological advancements in ELISA kit manufacturing are resulting in introduction of novel products with better performance characteristics, which is propelling the market growth.
- Growing awareness about benefits offered by rabbit ELISA kits over other conventional methods is fueling their adoption across end-use industries.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rabbit ELISA Kits Market Research Report
By Type
Unconjugated, Alkaline Phosphatase, Biotin, Others
By Application
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
By Companies
Abbexa Ltd, Antibodies-online, Aviva Systems Biology, Bioassay Technology Laboratory, Biomatik, Biorbyt, BioVision, CUSABIO Technology LLC, G Biosciences, LifeSpan BioSciences, MyBioSource.com, Nordic BioSite, Novus Biologicals, XpressBio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Rabbit ELISA Kits Market Report Segments:
The global Rabbit ELISA Kits market is segmented on the basis of:
Types
Unconjugated, Alkaline Phosphatase, Biotin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbexa Ltd
- Antibodies-online
- Aviva Systems Biology
- Bioassay Technology Laboratory
- Biomatik
- Biorbyt
- BioVision
- CUSABIO Technology LLC
- G Biosciences
- LifeSpan BioSciences
- MyBioSource.com
- Nordic BioSite
- Novus Biologicals
- XpressBio
Highlights of The Rabbit ELISA Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Unconjugated
- Alkaline Phosphatase
- Biotin
- Others
- By Application:
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rabbit ELISA Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rabbit ELISA Kits are a type of antibody assay used to detect the presence of specific proteins in biological samples.
Some of the key players operating in the rabbit elisa kits market are Abbexa Ltd, Antibodies-online, Aviva Systems Biology, Bioassay Technology Laboratory, Biomatik, Biorbyt, BioVision, CUSABIO Technology LLC, G Biosciences, LifeSpan BioSciences, MyBioSource.com, Nordic BioSite, Novus Biologicals, XpressBio.
The rabbit elisa kits market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rabbit ELISA Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rabbit ELISA Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rabbit ELISA Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rabbit ELISA Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rabbit ELISA Kits Market Size & Forecast, 2020-2028
4.5.1 Rabbit ELISA Kits Market Size and Y-o-Y Growth
4.5.2 Rabbit ELISA Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Unconjugated
5.2.2 Alkaline Phosphatase
5.2.3 Biotin
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals & Diagnostic Laboratories
6.2.2 Pharmaceutical & Biotechnology
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rabbit ELISA Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rabbit ELISA Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Unconjugated
9.6.2 Alkaline Phosphatase
9.6.3 Biotin
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals & Diagnostic Laboratories
9.10.2 Pharmaceutical & Biotechnology
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Unconjugated
10.6.2 Alkaline Phosphatase
10.6.3 Biotin
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals & Diagnostic Laboratories
10.10.2 Pharmaceutical & Biotechnology
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Unconjugated
11.6.2 Alkaline Phosphatase
11.6.3 Biotin
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals & Diagnostic Laboratories
11.10.2 Pharmaceutical & Biotechnology
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Unconjugated
12.6.2 Alkaline Phosphatase
12.6.3 Biotin
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals & Diagnostic Laboratories
12.10.2 Pharmaceutical & Biotechnology
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Unconjugated
13.6.2 Alkaline Phosphatase
13.6.3 Biotin
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals & Diagnostic Laboratories
13.10.2 Pharmaceutical & Biotechnology
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rabbit ELISA Kits Market: Competitive Dashboard
14.2 Global Rabbit ELISA Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbexa Ltd
14.3.2 Antibodies-online
14.3.3 Aviva Systems Biology
14.3.4 Bioassay Technology Laboratory
14.3.5 Biomatik
14.3.6 Biorbyt
14.3.7 BioVision
14.3.8 CUSABIO Technology LLC
14.3.9 G Biosciences
14.3.10 LifeSpan BioSciences
14.3.11 MyBioSource.com
14.3.12 Nordic BioSite
14.3.13 Novus Biologicals
14.3.14 XpressBio
